New SPARK program in Denmark

The SPARK Europe network is growing once again with a new charter in Denmark being established.

SPARK Denmark is supported with a grant of DKK 44 million (approximately € 5,9 million) from the Novo Nordisk Foundation and will be established at Denmark’s five largest universities. As one of the leading nations in basic research and the life sciences the Nordic country can account for a high number of registered patents per capita in biotechnology and medical technology. Unfortunately, this excellent track record is not reflected in the number of new products and solutions reaching the market. SPARK Denmark seeks to address this gap and support with funding and commercial expertise.

As all SPARK charters worldwide, SPARK Denmark supports the translation of promising academic projects to increase the chance that medical innovations reach the market and may benefit patients and society. This support exceeds the national level, as SPARK researchers join an international SPARK network that provides access to a wide range of industry experts serving as mentors, start-up capital, training seminars and international SPARK Summits.

The SPARK innovation program has originally been established at Stanford University in 2006. Since then, SPARK has become a global program that has been rolled out at 40 research institutions, including the SPARK program at the Berlin Institute of Health at Charité. The European SPARK network is already actively collaborating in providing education and joint mentoring events. SPARK Denmark brings new opportunities for deeper and more versatile collaboration in future. “We are proud to welcome SPARK Denmark to our growing European SPARK network. The support by the Novo Nordisk Foundation represents a recognition for the SPARK innovation program and further enables product/solution development for the benefit of patients and society,” says Dr. Tanja Rosenmund, Head of SPARK-BIH.

More information

SPARK-BIH is a member of the SPARK Global network